NYSE ARCA | ETF
The fund generally will invest at least 80% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents.
The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. -null-.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 6.12% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 4.39% |
| SAN | Sanofi SA | Healthcare | Drug Manufacturers - General | 4.36% |
| GSK | GlaxoSmithKline PLC | Healthcare | Drug Manufacturers - General | 4.30% |
| 6160 | Beigene Ltd | Healthcare | Biotechnology | 4.29% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 4.22% |
| AZN | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 4.22% |
| SRPT | Sarepta Therapeutics Inc | Healthcare | Biotechnology | 4.21% |
| ROG | Roche Holding AG | Healthcare | Drug Manufacturers - General | 4.20% |
| 4502 | Takeda Pharmaceutical Co. Ltd. | Healthcare | Drug Manufacturers - Specialty & Generic | 4.14% |
| GMAB | Genmab A/S | Healthcare | Biotechnology | 4.12% |
| BNTX | BioNTech SE | Healthcare | Biotechnology | 4.10% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 4.10% |
| EXEL | Exelixis Inc | Healthcare | Biotechnology | 4.07% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 4.01% |
| RVMD | Revolution Medicines Inc | Healthcare | Biotechnology | 3.84% |
| TWST | Twist Bioscience Corp | Healthcare | Diagnostics & Research | 3.71% |
| ACLX | Arcellx Inc | Healthcare | Biotechnology | 3.54% |
| SWTX | SpringWorks Therapeutics Inc | Healthcare | Biotechnology | 3.29% |
| JANX | Janux Therapeutics Inc | Healthcare | Biotechnology | 3.23% |